NCT01983488

Brief Summary

This study is aimed at investigating the long term clinical outcome of patients with uveitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
231

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 14, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

March 1, 2021

Status Verified

February 1, 2021

Enrollment Period

7.3 years

First QC Date

November 3, 2013

Last Update Submit

February 25, 2021

Conditions

Uveitis

Keywords

UveitisVision Loss

Outcome Measures

Primary Outcomes (1)

  • Best Corrected Visual Acuity

    Recorded repeat best corrected visual acuity at intervals throughout the length of follow-up.

    up to 10 years

Secondary Outcomes (1)

  • Causes of visual loss

    First follow-up, years 1,2,5,10, Final follow-up

Study Arms (1)

Uveitis

Patient with a clinical diagnosis of Uveitis.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient data will be gathered from the uveitis clinic at Moorfields Eye Hospital.

You may qualify if:

  • Clinical Diagnosis of Uveitis.

You may not qualify if:

  • No follow-up data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moorfields Eye Hospital

London, EC1V 2PD, United Kingdom

Location

Related Publications (2)

  • Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996 Apr;80(4):332-6. doi: 10.1136/bjo.80.4.332.

    PMID: 8703885BACKGROUND

  • Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, Huong DL, Piette JC, LeHoang P. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001 Jul;80(4):263-70. doi: 10.1097/00005792-200107000-00005. No abstract available.

    PMID: 11470987BACKGROUND

MeSH Terms

Conditions

UveitisVision Disorders

Condition Hierarchy (Ancestors)

Uveal DiseasesEye DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sue Lightman, PhD,FRCOphth

    Moorfields Eye Hospital NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Ophthalmology

Study Record Dates

First Submitted

November 3, 2013

First Posted

November 14, 2013

Study Start

September 1, 2011

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

March 1, 2021

Record last verified: 2021-02

Locations

GB(1)